Dr. Janice Wang is the Director of the Adult Cystic Fibrosis (CF) Clinical Program in the Division of Pulmonary, Critical Care, and Sleep Medicine at the Long Island Jewish Medical Center of Northwell Health, and she serves as the Center’s adult therapeutic development network center director. She has experience in the design and performance of investigator-initiated studies and serves as a site investigator for many industry-sponsored clinical trials in order to facilitate the performance of cutting-edge Phase 2 and 3 drug trials from the CF pipeline, as well as innovative observational trials analyzing understudied CF-related complications. Dr. Wang demonstrates mentoring, teaching, and educational leadership to physicians-in-training. She educates medical students, physicians, and her patients with CF and their caregivers through local seminars, town halls, and national conferences. She has received multiple grants, as a principal investigator, from the Cystic Fibrosis Foundation. Dr. Wang has been actively involved in COVID-19 clinical trials, both industry-sponsored and investigator-initiated, with a focus on anticoagulation in critically ill patients and the pandemic's impact on people with CF. Her interests include CF, bronchiectasis, nontuberculous mycobacteria disease, sleep medicine, and critical care.